​
​

Sunshine Biopharma Ownership 2024 | Who Owns Sunshine Biopharma Now?

OverviewRevenueFinancialsChart

Institutional Ownership

0.00%

Insider Ownership

0.41%

Retail Ownership

99.58%

Institutional Holders

1.00

Sunshine Biopharma Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RISE ADVISORS, LLC----18-100.00%-Jun 30, 2024

Sunshine Biopharma's largest institutional shareholder is RISE ADVISORS, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RISE ADVISORS, LLC----18-100.00%-Jun 30, 2024

The largest Sunshine Biopharma shareholder by % of total assets is RISE ADVISORS, LLC. The company owns 0.00 shares of Sunshine Biopharma (SBFM), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RISE ADVISORS, LLC----18-100.00%-Jun 30, 2024

As of Jun 30 2024, Sunshine Biopharma's largest institutional buyer is RISE ADVISORS, LLC. The company purchased -18.00 stocks of SBFM, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RISE ADVISORS, LLC----18-100.00%-Jun 30, 2024

As of Jun 30 2024, Sunshine Biopharma's biggest institutional seller is RISE ADVISORS, LLC. The company sold -18.00 shares of SBFM, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RISE ADVISORS, LLC----18-100.00%-Jun 30, 2024

Sunshine Biopharma's largest sold out institutional shareholder by shares sold is RISE ADVISORS, LLC, sold -18.00 shares, valued at -, as of undefined.

Sunshine Biopharma Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
BRIDGEWAY FUNDS INC0.12%286,100--Mar 28, 2024
FIDELITY CONCORD STREET TRUST0.00%20,179--Feb 29, 2024

Sunshine Biopharma's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 286.10K shares, compromising 0.12% of its total assets.

Sunshine Biopharma Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 241-
31 Dec, 231-
30 Sep, 231-
30 Jun, 231-50.00%
31 Mar, 232-
31 Dec, 222-
30 Jun, 221-
31 Mar, 221-
31 Dec, 211-

As of 31 Mar 24, 1 institutions are holding Sunshine Biopharma's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2418-
31 Dec, 2318-
30 Sep, 2318-
30 Jun, 2318-52.63%
31 Mar, 2338-87.86%
31 Dec, 22313-
30 Jun, 221,464-
31 Mar, 221,464-99.50%
31 Dec, 21292,683-

Sunshine Biopharma (SBFM) has 18.00 shares outstanding as of 31 Mar 24, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 240.00%35714.29%
31 Dec, 230.00%35714.29%
30 Sep, 230.00%35714.29%
30 Jun, 230.00%8028.81%
31 Mar, 230.01%248.77%
31 Dec, 220.05%-
30 Jun, 220.23%438.02%
31 Mar, 220.23%0.01%
31 Dec, 2145.64%-

As of 31 Mar 24, Sunshine Biopharma is held by 0.00% institutional shareholders, representing a 35714.29% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 24--
31 Dec, 23--
30 Sep, 23--
30 Jun, 23--
31 Mar, 23--100.00%
31 Dec, 222-
30 Jun, 22--
31 Mar, 22--100.00%
31 Dec, 211-

- institutional shareholders have increased their position in SBFM stock as of 31 Mar 24 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 24--
31 Dec, 23--
30 Sep, 23--
30 Jun, 23--100.00%
31 Mar, 231-
31 Dec, 22--
30 Jun, 22--100.00%
31 Mar, 221-
31 Dec, 21--

- institutional shareholders have reduced their position in SBFM stock as of 31 Mar 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 241-18-0.00%35714.29%----
31 Dec, 231-18-0.00%35714.29%----
30 Sep, 231-18-0.00%35714.29%----
30 Jun, 231-50.00%18-52.63%0.00%8028.81%----100.00%
31 Mar, 232-38-87.86%0.01%248.77%--100.00%1-
31 Dec, 222-313-0.05%-2---
30 Jun, 221-1,464-0.23%438.02%----100.00%
31 Mar, 221-1,464-99.50%0.23%0.01%--100.00%1-
31 Dec, 211-292,683-45.64%-1---

Sunshine Biopharma Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 05, 2024Slilaty Steve N.director, 10 percent owner, officer Chief Executive OfficerP-PurchaseBuy100,000$0.10$10.00K130,000
Feb 12, 2024Slilaty Steve N.director, 10 percent owner, officer Chief Executive OfficerP-PurchaseBuy20,000$0.10$2.00K30,000
Dec 02, 2022Sebaaly Camilleofficer CFO/SecretaryP-PurchaseBuy30,000$0.76$22.91K174,465
Jun 06, 2022Sebaaly Camilleofficer CFO/SecretaryP-PurchaseBuy25,000$1.22$30.50K144,465

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 05, 2024Slilaty Steve N.director, 10 percent owner, officer Chief Executive OfficerP-PurchaseBuy100,000$0.10$10.00K130,000
Feb 12, 2024Slilaty Steve N.director, 10 percent owner, officer Chief Executive OfficerP-PurchaseBuy20,000$0.10$2.00K30,000
Dec 02, 2022Sebaaly Camilleofficer CFO/SecretaryP-PurchaseBuy30,000$0.76$22.91K174,465
Jun 06, 2022Sebaaly Camilleofficer CFO/SecretaryP-PurchaseBuy25,000$1.22$30.50K144,465

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Oct 26, 2022Chamoun Malekdirector-Sell---3,700,000
Feb 22, 2022Slilaty Steve N.director, officer Chief Executive OfficerD-ReturnSell990,000$0.10$99.00K10,000
Feb 18, 2022NATAN DAVIDdirector-Sell----
Feb 18, 2022Keller Andrew Markdirector-Sell----
Dec 16, 2021Kiderchah Rabidirector-Sell---325,000
Dec 14, 2021Kish James Danieldirector-Sell---287,100
Dec 09, 2021TELSEY ANDREW Idirector-Sell---3,000
Jul 15, 2020Sebaaly Camilledirector, officer CFO/SecretaryA-AwardSell323,673-$323.67-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 05, 2024Slilaty Steve N.director, 10 percent owner, officer Chief Executive OfficerP-PurchaseBuy100,000$0.10$10.00K130,000
Feb 12, 2024Slilaty Steve N.director, 10 percent owner, officer Chief Executive OfficerP-PurchaseBuy20,000$0.10$2.00K30,000
Feb 09, 2024Beaudoin Marcofficer-Buy----
Dec 02, 2022Sebaaly Camilleofficer CFO/SecretaryP-PurchaseBuy30,000$0.76$22.91K174,465
Oct 26, 2022Chamoun Malekdirector-Sell---3,700,000
Jun 06, 2022Sebaaly Camilleofficer CFO/SecretaryP-PurchaseBuy25,000$1.22$30.50K144,465
Feb 22, 2022Slilaty Steve N.director, officer Chief Executive OfficerD-ReturnSell990,000$0.10$99.00K10,000
Feb 18, 2022NATAN DAVIDdirector-Sell----
Feb 18, 2022Keller Andrew Markdirector-Sell----
Dec 16, 2021Kiderchah Rabidirector-Sell---325,000
Dec 14, 2021Kish James Danieldirector-Sell---287,100
Dec 14, 2021Kish James Danieldirector-Buy---2,500
Dec 09, 2021TELSEY ANDREW Idirector-Sell---3,000
Feb 16, 2021MERZOUKI ABDERRAZZAKdirector, officer Chief Operating OfficerA-AwardBuy20,000,000-$20.00K23,342,500
Feb 16, 2021Slilaty Steve N.director, officer Chief Executive OfficerA-AwardBuy20,000,000-$20.00K23,343,461
Feb 16, 2021Sebaaly Camilledirector, officer CFO/SecretaryA-AwardBuy20,000,000-$20.00K23,893,086
Jul 15, 2020Sebaaly Camilledirector, officer CFO/SecretaryA-AwardBuy1,300,000-$1.30K3,893,086
Jul 15, 2020Sebaaly Camilledirector, officer CFO/SecretaryA-AwardBuy1,100,000-$1.10K2,593,086
Jul 15, 2020Sebaaly Camilledirector, officer CFO/SecretaryA-AwardBuy550,000-$550.001,493,086
Jul 15, 2020Sebaaly Camilledirector, officer CFO/SecretaryA-AwardSell323,673-$323.67-

The last insider sell of Sunshine Biopharma's stock was made by Chamoun Malek on Oct 26 2022, selling - shares at - per share (valued at -). The last insider buy of SBFM was made by Slilaty Steve N. on Mar 05 2024, buying 100,000 shares at $0.10 per share (worth $10.00K).

Sunshine Biopharma Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 20242--
Q4 202211100.00%
Q2 20221--
Q1 2022-3-
Q4 2021-3-
Q1 20213--
Q2 20201--
Q4 201971700.00%
Q3 20195--
Q3 20184--
Q2 20185--
Q3 20174--
Q4 201652250.00%
Q3 201611100.00%
Q2 20164--
Q2 20151--
Q1 20151250.00%
Q3 2012-2-
Q4 201122100.00%
Q4 2009-3-

2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Sunshine Biopharma's insiders, as of Q1 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 20242--
Q4 20221--
Q2 20221--
Q1 2022---
Q4 2021---
Q1 2021---
Q2 2020---
Q4 2019---
Q3 2019---
Q3 2018---
Q2 2018---
Q3 2017---
Q4 2016---
Q3 2016---
Q2 20161--
Q2 20151--
Q1 2015---
Q3 2012-1-
Q4 2011---
Q4 2009---

As of Q1 2024, Insider owners conducted 2 open market buy trades and 0 open market sell trades of Sunshine Biopharma's stocks.

Sunshine Biopharma Peer Ownership

TickerCompany
SNOASonoma Pharmaceuticals, Inc.
TKNOAlpha Teknova, Inc.
LFCRLifecore Biomedical, Inc.
PAHCPhibro Animal Health Corporation
GHSIGuardion Health Sciences, Inc.
ALIMAlimera Sciences, Inc.
SHPHShuttle Pharmaceuticals Holdings, Inc.
SSICSilver Spike Investment Corp.
DERMJourney Medical Corporation
PTPIPetros Pharmaceuticals, Inc.
SXTCChina SXT Pharmaceuticals, Inc.
EGRXEagle Pharmaceuticals, Inc.

SBFM Ownership FAQ

Sunshine Biopharma is owned by institutional shareholders (0.00%), insiders (0.41%), and public (99.58%). The largest institutional shareholder of Sunshine Biopharma is RISE ADVISORS, LLC (0% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.12% of total shares).

Sunshine Biopharma's major institutional shareholders are RISE ADVISORS, LLC. The top five shareholders own together 0% of the company's share outstanding.

As of Mar 2024, there are 1 institutional shareholders of Sunshine Biopharma.

RISE ADVISORS, LLC owns 0 shares of Sunshine Biopharma, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).